Drug
Sulopenem
Sulopenem is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Phase Distribution
Ph phase_3
2
67%
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (33.3%)
Phase 32 (66.7%)
Trials by Status
completed267%
withdrawn133%
Recent Activity
0 active trials
Showing 3 of 3
withdrawnphase_1
Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents
NCT04700787
completedphase_3
Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults
NCT03357614
completedphase_3
Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)
NCT03358576
Clinical Trials (3)
Showing 3 of 3 trials
NCT04700787Phase 1
Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents
NCT03357614Phase 3
Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults
NCT03358576Phase 3
Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3